-
Posted by
Two Blokes Fri at 3:00 PM -
Filed in
Stock
-
2 views
Puma Biotechnology PBYI reported first-quarter 2025 adjusted earnings of 10 cents per share, which beat the Zacks Consensus Estimate of 2 cents. In the year-ago quarter, the company had incurred a loss of 5 cents per share.
